Bartosik-Psujek H

References (4)

Title : Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients - Jamroz-Wisniewska_2020_Oxid.Med.Cell.Longev_2020_1654754
Author(s) : Jamroz-Wisniewska A , Beltowski J , Wojcicka G , Bartosik-Psujek H , Rejdak K
Ref : Oxid Med Cell Longev , 2020 :1654754 , 2020
Abstract :
PubMedSearch : Jamroz-Wisniewska_2020_Oxid.Med.Cell.Longev_2020_1654754
PubMedID: 32256946

Title : Processes of plasma protein N-homocysteinylation in multiple sclerosis - Jamroz-Wisniewska_2017_Int.J.Neurosci_127_709
Author(s) : Jamroz-Wisniewska A , Beltowski J , Bartosik-Psujek H , Wojcicka G , Rejdak K
Ref : International Journal of Neuroscience , 127 :709 , 2017
Abstract :
PubMedSearch : Jamroz-Wisniewska_2017_Int.J.Neurosci_127_709
PubMedID: 27671515

Title : Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy - Jamroz-Wisniewska_2013_Acta.Neurol.Scand_127_e33
Author(s) : Jamroz-Wisniewska A , Beltowski J , Stelmasiak Z , Bartosik-Psujek H
Ref : Acta Neurologica Scandinavica , 127 :e33 , 2013
Abstract :
PubMedSearch : Jamroz-Wisniewska_2013_Acta.Neurol.Scand_127_e33
PubMedID: 22881373

Title : Paraoxonase 1 activity in different types of multiple sclerosis - Jamroz-Wisniewska_2009_Mult.Scler_15_399
Author(s) : Jamroz-Wisniewska A , Beltowski J , Stelmasiak Z , Bartosik-Psujek H
Ref : Mult Scler , 15 :399 , 2009
Abstract :
PubMedSearch : Jamroz-Wisniewska_2009_Mult.Scler_15_399
PubMedID: 18845659